$3.62
-0.04-1.09%
Last update: Nov 2, 9:26 AM
Bicycle Therapeutics PLC
BCYCNASDAQ
Bicycle Therapeutics (BCYC) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
| Metric | Q3 '26 | Q2 '26 | Q1 '26 | Q4 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $-0.43 | $-0.53 | $-0.62 | $-0.97 |
| Actual | $-0.15 | $-0.72 | $-0.87 | $-0.29 |
| Surprise | +65.1% | -35.9% | -40.3% | +70.1% |
| Revenue | ||||
| Estimate | $14.0M | $5.4M | $7.6M | $8.3M |
| Actual | $34.1M | $629000 | $887000 | $48.0M |
| Surprise | +143.6% | -88.4% | -88.4% | +478.2% |
| Metric | Q4 '26E | Q1 '27E |
|---|---|---|
| Earnings Per Share (Non-GAAP) | ||
| Consensus | $-0.44 | $-0.59 |
| Revenue | ||
| Consensus | $6.6M | $1.1M |
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q3 | Oct 29, 2026 | $-0.15 | $-0.43 | 65.1 % |
| Q2 | Jul 30, 2026 | $-0.72 | $-0.53 | -35.9 % |
| Q1 | Apr 30, 2026 | $-0.87 | $-0.62 | -40.3 % |
| Q4 | Mar 17, 2026 | $-0.29 | $-0.97 | 70.1 % |
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q3 | Oct 29, 2026 | $34.06M | $13.98M | 143.6 % |
| Q2 | Jul 30, 2026 | $629.00K | $5.42M | -88.4 % |
| Q1 | Apr 30, 2026 | $887.00K | $7.62M | -88.4 % |
| Q4 | Mar 17, 2026 | $47.96M | $8.29M | 478.2 % |
